In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

(2021) Robert L. Gottlieb et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

In silico analyses on the comparative sensing of SARS‐CoV‐2 mRNA by the intracellular TLRs of humans

(2021) Abhigyan Choudhury et al.   JOURNAL OF MEDICAL VIROLOGY

iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus

(2021) Phuc-Chau Do et al.   PLoS One

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

(2021) Cheolmin Kim et al.   Nature Communications

Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases

(2021) Aristo Vojdani et al.   Frontiers in Immunology

Rationally Designed Chimeric Antibodies for COVID-19 and Future Coronavirus Variants

(2021) Ching-chung Hsueh et al.   BIOPHYSICAL JOURNAL

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

(2021) Pengfei Wang et al.   NATURE

Lifestyle and mental health disruptions during COVID-19

(2021) Osea Giuntella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Computational discovery and ex-vivo validation study of novel antigenic vaccine candidates against tuberculosis

(2021) Aregitu Mekuriaw Arega et al.   ACTA TROPICA

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

(2021) Abhigyan Choudhury et al.   Future Virology

In-silico evidences on filarial cystatin as a putative ligand of human TLR4

(2021) Nabarun Chandra Das et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant

(2021) Dong-Kyun Ryu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

In silico identification of new anti-SARS-CoV-2 agents from bioactive phytocompounds targeting the viral spike glycoprotein and human TLR4

(2021) Nabarun Chandra Das et al.   Letters in Drug Design & Discovery

SARS-CoV-2 variants of concern are emerging in India

(2021) Jasdeep Singh et al.   NATURE MEDICINE

SARS-CoV-2 variants, spike mutations and immune escape

(2021) William T. Harvey et al.   NATURE REVIEWS MICROBIOLOGY

Current status of therapeutic monoclonal antibodies against SARS-CoV-2

(2021) Sanjeev Kumar et al.   PLoS Pathogens

A Future Forecasting for FMCG Firm Performance in Covid-19: An Investigation of Consumer and Business Survival

(2021) Yunpeng Sun et al.   Frontiers in Public Health

Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations

(2021) Damiano Buratto et al.   Frontiers in Immunology

In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs

(2020) Abhigyan Choudhury et al.   JOURNAL OF MEDICAL VIROLOGY

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig

(2020) Changhai Lei et al.   Nature Communications

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

(2020) Yuan Huang et al.   ACTA PHARMACOLOGICA SINICA

Targeting human TLRs to combat COVID‐19: A solution?

(2020) Ritwik Patra et al.   JOURNAL OF MEDICAL VIROLOGY

Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2

(2020) Parismita Kalita et al.   MICROBIAL PATHOGENESIS

Antibody-protein binding and conformational changes: identifying allosteric signalling pathways to engineer a better effector response

(2020) Mohammed M. Al Qaraghuli et al.   Scientific Reports

Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment

(2020) Felipe Saldanha-Araujo et al.   Frontiers in Immunology

Structure-based drug designing and immunoinformatics approach for SARS-CoV-2

(2020) Pritam Kumar Panda et al.   Science Advances

CoV-AbDab: the Coronavirus Antibody Database

(2020) Matthew I J Raybould et al.   BIOINFORMATICS

Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies

(2020) Praveen Mathews Varghese et al.   IMMUNOBIOLOGY

The coronavirus is mutating — does it matter?

(2020) Ewen Callaway   NATURE

In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli

(2020) Sara Hasanzadeh et al.   Scientific Reports

Designing of a novel multi-epitope peptide based vaccine against Brugia malayi: An in silico approach

(2020) Nabarun Chandra Das et al.   INFECTION GENETICS AND EVOLUTION

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

(2020) David M. Weinreich et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

(2020) Peter Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management

(2020) Abubakar Umar Anka et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters

(2020) Anna C. Fagre et al.   Frontiers in Immunology

Five computational developability guidelines for therapeutic antibody profiling

(2019) Matthew I. J. Raybould et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Computational approaches to therapeutic antibody design: established methods and emerging trends

(2019) Richard A Norman et al.   BRIEFINGS IN BIOINFORMATICS

Using Omics Technologies and Systems Biology to Identify Epitope Targets for the Development of Monoclonal Antibodies Against Antibiotic-Resistant Bacteria

(2019) Antonio J. Martín-Galiano et al.   Frontiers in Immunology

Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection

(2018) Aruna Narula et al.   INFECTION GENETICS AND EVOLUTION

SWISS-MODEL: homology modelling of protein structures and complexes

(2018) Andrew Waterhouse et al.   NUCLEIC ACIDS RESEARCH

In vitro and in silico assessment of the developability of a designed monoclonal antibody library

(2018) Adriana-Michelle Wolf Pérez et al.   mAbs

The use of databases, data mining and immunoinformatics in vaccinology: where are we?

(2017) Nagendra R. Hegde et al.   Expert Opinion on Drug Discovery

PRODIGY: a web server for predicting the binding affinity of protein–protein complexes

(2016) Li C. Xue et al.   BIOINFORMATICS

The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes

(2016) G.C.P. van Zundert et al.   JOURNAL OF MOLECULAR BIOLOGY

ABodyBuilder: Automated antibody structure prediction with data–driven accuracy estimation

(2016) Jinwoo Leem et al.   mAbs

SAbPred: a structure-based antibody prediction server

(2016) James Dunbar et al.   NUCLEIC ACIDS RESEARCH

Prediction of CD8+ Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation

(2015) Angelo Duarte et al.   PLoS One

Improving B-cell epitope prediction and its application to global antibody-antigen docking

(2014) Konrad Krawczyk et al.   BIOINFORMATICS

iMODS: internal coordinates normal mode analysis server

(2014) José Ramón López-Blanco et al.   NUCLEIC ACIDS RESEARCH

Antibody i-Patch prediction of the antibody binding site improves rigid local antibody-antigen docking

(2013) K. Krawczyk et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Polytope DNA Vaccine Development Against Hepatitis C Virus: A Streamlined Approach from In Silico Design to In Vitro and Primary In Vivo Analyses in BALB/c Mice

(2010) Arash Memarnejadian et al.   PROTEIN AND PEPTIDE LETTERS

Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering

(2008) Thibaut Pelat et al.   JOURNAL OF MOLECULAR BIOLOGY